728 A phase 1/2 study of JK08, an IL-15 antibody fusion protein targeting CTLA-4, in patients with advanced solid tumorsNuria Kotecki, Naimish Pandya, Vladimir Galvao et al.|Regular and Young Investigator Award Abstracts|2023Cited by 1
A phase 1/2 study of JK06, a 5T4 antibody drug conjugate, in patients with unresectable locally advanced or metastatic cancer.Nuria Kotecki, Naimish Pandya, Sylvie Rottey et al.|Journal of Clinical Oncology|2025Cited by 0